levetiracetam
Generic: levetiracetam
Labeler: exelan pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
levetiracetam
Generic Name
levetiracetam
Labeler
exelan pharmaceuticals, inc.
Dosage Form
TABLET
Routes
Active Ingredients
levetiracetam 250 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76282-246
Product ID
76282-246_b044e723-e969-45fa-a4e6-159bfb65267a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA078234
Listing Expiration
2026-12-31
Marketing Start
2009-01-15
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76282246
Hyphenated Format
76282-246
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
levetiracetam (source: ndc)
Generic Name
levetiracetam (source: ndc)
Application Number
ANDA078234 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
Packaging
- 120 TABLET in 1 BOTTLE (76282-246-12)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b044e723-e969-45fa-a4e6-159bfb65267a", "openfda": {"nui": ["N0000008486"], "upc": ["0376282248127", "0376282247120", "0376282246123"], "unii": ["44YRR34555"], "rxcui": ["311288", "311289", "311290"], "spl_set_id": ["28c0e61e-1af9-410a-9fa9-b71bf99a776b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Exelan Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (76282-246-12)", "package_ndc": "76282-246-12", "marketing_start_date": "20090115"}], "brand_name": "Levetiracetam", "product_id": "76282-246_b044e723-e969-45fa-a4e6-159bfb65267a", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "76282-246", "generic_name": "Levetiracetam", "labeler_name": "Exelan Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "250 mg/1"}], "application_number": "ANDA078234", "marketing_category": "ANDA", "marketing_start_date": "20090115", "listing_expiration_date": "20261231"}